Article Details

Samsung Biologics to provide end-to-end mRNA vaccine manufacturing

Retrieved on: 2021-05-31 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Samsung Biologics to provide end-to-end mRNA vaccine manufacturing. View article details on hiswai:

Excerpt

Expansion plans. Samsung Biologics has set out its ambition to be a 'full-service biopharmaceutical company'.​​ Its biggest project for 2021 will be to ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up